The role of NK cells in HIV and tuberculosis co-infection

NK 细胞在 HIV 和结核病合并感染中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Over the past 10 years, we have published a series of articles demonstrating that human NK cells have the potential to contribute to both innate and adaptive immune responses to M. tb. NK cells lyse M. tb-infected alveolar macrophages and produce IL-22, which inhibits intracellular growth of M. tb. NK cells also enhance T-cell responses by lysing M. tb-expanded immunosuppressive CD4+ regulatory T cells (Tregs) and by upregulating CD8+ T-cell responses in persons with LTBI. Our recent unpublished data also show NK cells contribute to T-cell responses to BCG vaccination. Since 2007, we have been collaborating with Dr. Vijaya Valluri at the Blue Peter Research Center, LEPRA Society, Hyderabad, India on studies of NK cells and Tregs. Based on our data and our established collaboration with Dr. Valluri's group, We propose the following aims. 1) Determine if NK cell responses to M. tb are reduced in HIV+ persons with LTBI. We will compare the capacity of NK cells from HIV- and HIV+ persons, with or without LTBI, to mediate innate responses to M. tb and evaluate the capacity of NK cells from HIV- and HIV+ persons, with or without LTBI, to affect T-cell responses 2) Determine if immune-based interventions can enhance NK cell and T-cell function in HIV+ persons with LTBI and active TB. We will devise interventions to improve NK cell function in HIV+ persons with LTBI, determine if interventions to improve NK cell function also enhance T-cell function in HIV+ persons with LTBI and determine if they enhance NK cell and T-cell function in HIV+ persons with active TB. PUBLIC HEALTH RELEVANCE: Mycobacterium tuberculosis infects one-third of the world's population and causes almost 2 million deaths per year. HIV infection markedly increases susceptibility to TB, and HIV-infected persons with latent tuberculosis infection (LTBI) have an 800-fold greater risk of developing active TB. The proposed studies will improve our understanding of the mechanisms that mediate susceptibility to TB in HIV+ persons, and facilitate development of interventions to improve NK cell function and prevent progression of LTBI in HIV-infected persons.
描述(由申请人提供):在过去10年中,我们发表了一系列文章,证明人NK细胞具有促进对M的先天性和适应性免疫应答的潜力。TB. NK细胞裂解M.肺结核感染的肺泡巨噬细胞产生IL-22,IL-22抑制M. TB. NK细胞还通过溶解M增强T细胞应答。TB-扩增的免疫抑制性CD 4+调节性T细胞(T细胞)和上调LTBI患者的CD 8 + T细胞应答。我们最近未发表的数据也表明NK细胞有助于T细胞对BCG疫苗接种的反应。自2007年以来,我们一直与印度海得拉巴LEPRA协会Blue Peter研究中心的Vijaya Vadii博士合作研究NK细胞和TcB。根据我们的数据和我们与Vesli博士小组建立的合作关系,我们提出以下目标。1)确定NK细胞是否对M.结核病在HIV阳性的LTBI患者中减少。我们将比较来自HIV-和HIV+患者的NK细胞在有或没有LTBI的情况下介导对M. 2)确定基于免疫的干预是否可以增强患有LTBI和活动性TB的HIV+患者的NK细胞和T细胞功能。我们将设计干预措施来改善HIV+ LTBI患者的NK细胞功能,确定改善NK细胞功能的干预措施是否也能增强HIV+ LTBI患者的T细胞功能,并确定它们是否能增强HIV+活动性TB患者的NK细胞和T细胞功能。 公共卫生相关性:结核分枝杆菌感染了世界三分之一的人口,每年造成近200万人死亡。艾滋病毒感染显著增加了对结核病的易感性,潜伏性结核病感染(LTBI)的艾滋病毒感染者患活动性结核病的风险增加了800倍。拟议的研究将提高我们对介导HIV+人群对TB易感性的机制的理解,并促进干预措施的开发,以改善NK细胞功能并预防HIV感染者LTBI的进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ramakrishna Vankayalapati其他文献

Ramakrishna Vankayalapati的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ramakrishna Vankayalapati', 18)}}的其他基金

Innate immune response of LTBI+HIV+ children
LTBI HIV 儿童的先天免疫反应
  • 批准号:
    10470320
  • 财政年份:
    2020
  • 资助金额:
    $ 19.39万
  • 项目类别:
Innate immune response of LTBI+HIV+ children
LTBI HIV 儿童的先天免疫反应
  • 批准号:
    10263218
  • 财政年份:
    2020
  • 资助金额:
    $ 19.39万
  • 项目类别:
IFN-γ independent inhibition of MTB growth in human macrophages
IFN-γ 独立抑制人巨噬细胞中 MTB 的生长
  • 批准号:
    9238190
  • 财政年份:
    2017
  • 资助金额:
    $ 19.39万
  • 项目类别:
IFN-γ independent inhibition of MTB growth in human macrophages
IFN-γ 独立抑制人巨噬细胞中 MTB 的生长
  • 批准号:
    9913448
  • 财政年份:
    2017
  • 资助金额:
    $ 19.39万
  • 项目类别:
Monocyte subpopulation in HIV+LTB+ individuals and development of active TB
HIV LTB 个体中的单核细胞亚群与活动性结核病的发展
  • 批准号:
    9333189
  • 财政年份:
    2016
  • 资助金额:
    $ 19.39万
  • 项目类别:
The role of NK cells in HIV and tuberculosis co-infection
NK 细胞在 HIV 和结核病合并感染中的作用
  • 批准号:
    8337399
  • 财政年份:
    2011
  • 资助金额:
    $ 19.39万
  • 项目类别:
Treg suppression of islet allograft rejection
Treg 抑制胰岛同种异体移植排斥
  • 批准号:
    8277367
  • 财政年份:
    2010
  • 资助金额:
    $ 19.39万
  • 项目类别:
Treg suppression of islet allograft rejection
Treg 抑制胰岛同种异体移植排斥
  • 批准号:
    8477114
  • 财政年份:
    2010
  • 资助金额:
    $ 19.39万
  • 项目类别:
The mechanisms of regulatory T-cell expansion in human Mycobacterium tuberculosis
人结核分枝杆菌调节性 T 细胞扩增的机制
  • 批准号:
    8145096
  • 财政年份:
    2010
  • 资助金额:
    $ 19.39万
  • 项目类别:
Treg suppression of islet allograft rejection
Treg 抑制胰岛同种异体移植排斥
  • 批准号:
    8664335
  • 财政年份:
    2010
  • 资助金额:
    $ 19.39万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 19.39万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 19.39万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 19.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了